Active Ingredient(s): Avatrombopag Maleate
FDA Approved: * May 21, 2018
Pharm Company: * AKARX INC
Category: Blood Volume

Avatrombopag, sold under the brand name Doptelet, is a medication that used for certain conditions that lead to thrombocytopenia (low platelets) such as thrombocytopenia associated with chronic liver disease in adults who are to undergo a planned medical or dental procedure.[1][2] It was approved for medical use in the United States in 2018,[3][4] and in the European Union in 2019.[5] It acts as a thrombopoietin ... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Doptelet 20 mg Oral Tablet, Film Coated
NDC: 71369-020
Akarx, Inc.